RLYB insider filings

Rallybio Corp — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-05. Screen RLYB transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 17 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Lieber Jonathan I — Chief Financial Officer5—1 leg · 599 sh · $9,60811
HUNT RONALD — Director2——8
Hopfner Robert Lorne — Director1——6
MACKAY MARTIN — Director1——6
Chung Wendy — Director2——4
Liu Hui — Director1——4
Uden Stephen — Chief Executive Officer, Director2——4
Boudreau Helen M — Director1——2
Nash Christine A — Director1——2
Soteropoulos Paula — Director1——2

Recent insider filings — Rallybio Corp

FiledFormInsiderReported transactionsSource
2026-11-054HUNT RONALD — DirectorOption exercise (M): 14,305 @ $4.45 · Option exercise (M): 14,305 (derivative) @ $3.60EDGAR
2026-11-054MACKAY MARTIN — DirectorOption exercise (M): 11,607 @ $7.60 · Option exercise (M): 3,562 @ $2.38 · Option exercise (M): 18,055 @ $4.45 · Option exercise (M): 11,607 (derivative) @ $5.60 · Option exercise (M): 3,562 (derivative) @ $0 · Option exercise (M): 18,055 (derivative) @ $3.60EDGAR
2026-11-034Lieber Jonathan I — Chief Financial OfficerOption exercise (M): 7,124 @ $14.88 · Option exercise (M): 7,124 (derivative) @ $0EDGAR
2026-11-024Lieber Jonathan I — Chief Financial OfficerOption exercise (M): 7,875 @ $14.88 · Option exercise (M): 13,589 @ $6.08 · Option exercise (M): 7,875 (derivative) @ $0 · Option exercise (M): 13,589 (derivative) @ $0EDGAR
2026-11-024HUNT RONALD — DirectorOption exercise (M): 3,562 @ $2.38 · Option exercise (M): 9,196 @ $7.60 · Option exercise (M): 2,062 @ $15.28 · Option exercise (M): 3,562 (derivative) @ $0 · Option exercise (M): 9,196 (derivative) @ $5.60 · Option exercise (M): 2,062 (derivative) @ $0EDGAR
2026-10-304Nash Christine A — DirectorOption exercise (M): 3,562 @ $2.38 · Option exercise (M): 3,562 (derivative) @ $0EDGAR
2026-10-294Uden Stephen — Chief Executive Officer, DirectorOption exercise (M): 33,244 @ $6.08 · Option exercise (M): 33,244 (derivative) @ $0EDGAR
2026-10-284Lieber Jonathan I — Chief Financial OfficerGrant/award (A): 2,500 @ $0 · Sale (S): 599 @ $16.04EDGAR
2026-10-284Chung Wendy — DirectorOption exercise (M): 2,062 @ $15.28 · Option exercise (M): 2,062 (derivative) @ $0EDGAR
2026-10-204Soteropoulos Paula — DirectorOption exercise (M): 3,562 @ $2.38 · Option exercise (M): 3,562 (derivative) @ $0EDGAR
2026-10-204Boudreau Helen M — DirectorOption exercise (M): 2,062 @ $15.28 · Option exercise (M): 2,062 (derivative) @ $0EDGAR
2026-10-144Hopfner Robert Lorne — DirectorOption exercise (M): 9,196 @ $7.60 · Option exercise (M): 3,562 @ $2.38 · Option exercise (M): 2,062 @ $15.28 · Option exercise (M): 9,196 (derivative) @ $0.56 · Option exercise (M): 3,562 (derivative) @ $0 · Option exercise (M): 2,062 (derivative) @ $0EDGAR
2026-10-134Lieber Jonathan I — Chief Financial OfficerOption exercise (M): 3,910 @ $6.08 · Option exercise (M): 3,910 (derivative) @ $0EDGAR
2026-10-084Uden Stephen — Chief Executive Officer, DirectorOption exercise (M): 22,456 @ $6.08 · Option exercise (M): 22,456 (derivative) @ $0EDGAR
2026-10-014Lieber Jonathan I — Chief Financial OfficerOption exercise (M): 5,000 @ $6.08 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2026-09-284Liu Hui — DirectorOption exercise (M): 3,562 @ $2.38 · Option exercise (M): 8,482 @ $7.60 · Option exercise (M): 3,562 (derivative) @ $0 · Option exercise (M): 8,482 (derivative) @ $5.60EDGAR
2026-09-184Chung Wendy — DirectorOption exercise (M): 3,562 @ $2.38 · Option exercise (M): 3,562 (derivative) @ $0EDGAR
2026-07-104Boudreau Helen M — DirectorOption exercise (M): 3,562 @ $2.38 · Option exercise (M): 3,562 (derivative) @ $0EDGAR
2026-05-204ADAR1 Capital Management, LLC — 10% owner
Schneeberger Daniel — 10% owner
Purchase (P): 6,009 @ $13.98 · Purchase (P): 10,000 @ $13.98 · Purchase (P): 200 @ $13.80EDGAR
2026-05-154ADAR1 Capital Management, LLC — 10% owner
Schneeberger Daniel — 10% owner
Purchase (P): 4,081 @ $13.80 · Purchase (P): 75,178 @ $14 · Purchase (P): 100 @ $13.80 · Purchase (P): 200 @ $13.95EDGAR
2026-05-134ADAR1 Capital Management, LLC — 10% owner
Schneeberger Daniel — 10% owner
Purchase (P): 5,100 @ $14.00 · Purchase (P): 25,000 @ $14 · Purchase (P): 19,900 @ $14 · Purchase (P): 800 @ $13.83EDGAR
2026-05-064ADAR1 Capital Management, LLC — 10% owner
Schneeberger Daniel — 10% owner
Purchase (P): 3,900 @ $13.90 · Purchase (P): 116,904 @ $13.97 · Purchase (P): 35,101 @ $14.00EDGAR
2026-02-234Lieber Jonathan I — Chief Financial OfficerGrant/award (A): 2,500 @ $0 · Sale (S): 789 @ $5.06EDGAR
2026-02-204MACKAY MARTIN — DirectorGrant/award (A): 18,055 (derivative) @ $3.60EDGAR
2026-02-204HUNT RONALD — DirectorGrant/award (A): 14,305 (derivative) @ $3.60EDGAR
2025-05-154Chung Wendy — DirectorGrant/award (A): 28,500 (derivative) @ $0EDGAR
2025-05-154Liu Hui — DirectorGrant/award (A): 28,500 (derivative) @ $0EDGAR
2025-05-154Soteropoulos Paula — DirectorGrant/award (A): 28,500 (derivative) @ $0EDGAR
2025-05-154Boudreau Helen M — DirectorGrant/award (A): 28,500 (derivative) @ $0EDGAR
2025-05-154Nash Christine A — DirectorGrant/award (A): 28,500 (derivative) @ $0EDGAR
2025-05-154Hopfner Robert Lorne — DirectorGrant/award (A): 28,500 (derivative) @ $0EDGAR
2025-05-154MACKAY MARTIN — DirectorGrant/award (A): 28,500 (derivative) @ $0EDGAR
2025-05-154HUNT RONALD — DirectorGrant/award (A): 28,500 (derivative) @ $0EDGAR
2025-02-194Ryder Steven — Chief Medical OfficerGrant/award (A): 180,000 (derivative) @ $0EDGAR
2025-02-194Lieber Jonathan I — Chief Financial OfficerGrant/award (A): 180,000 (derivative) @ $0EDGAR
2025-02-194Uden Stephen — Chief Executive Officer, DirectorGrant/award (A): 453,700 (derivative) @ $0EDGAR
2025-01-064Liu Hui — DirectorGrant/award (A): 67,857 (derivative) @ $0.70EDGAR
2025-01-064Hopfner Robert Lorne — DirectorGrant/award (A): 73,571 (derivative) @ $0.70EDGAR
2025-01-064MACKAY MARTIN — DirectorGrant/award (A): 92,857 (derivative) @ $0.70EDGAR
2025-01-064HUNT RONALD — DirectorGrant/award (A): 73,571 (derivative) @ $0.70EDGAR
2024-05-174Liu Hui — DirectorGrant/award (A): 16,500 (derivative) @ $0EDGAR
2024-05-174Chung Wendy — DirectorGrant/award (A): 16,500 (derivative) @ $0EDGAR
2024-05-174Soteropoulos Paula — DirectorGrant/award (A): 16,500 (derivative) @ $0EDGAR
2024-05-174PARMAR KUSH — DirectorGrant/award (A): 16,500 (derivative) @ $0EDGAR
2024-05-174Boudreau Helen M — DirectorGrant/award (A): 16,500 (derivative) @ $0EDGAR
2024-05-174Nash Christine A — DirectorGrant/award (A): 16,500 (derivative) @ $0EDGAR
2024-05-174Hopfner Robert Lorne — DirectorGrant/award (A): 16,500 (derivative) @ $0EDGAR
2024-05-174HUNT RONALD — DirectorGrant/award (A): 16,500 (derivative) @ $0EDGAR
2024-02-164Lieber Jonathan I — Chief Financial OfficerGrant/award (A): 120,000 (derivative) @ $0EDGAR
2024-02-164Uden Stephen — Chief Executive Officer, DirectorGrant/award (A): 216,000 (derivative) @ $0EDGAR

Recent 8-K events — Rallybio Corp

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-128-K8.01 — Other EventsEDGAR
2026-11-108-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-068-K8.01 — Other EventsEDGAR
2026-11-048-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-268-K8.01 — Other EventsEDGAR
2026-09-098-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-018-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-048-K1.02 — Termination of a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-318-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-03-028-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=RLYB returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs